deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02004275

Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Multiple Myeloma in Relapse
Interventions dexamethasone ixazomib pomalidomide
Updated 35 times since 2017 Last updated: Nov 9, 2023 Started: Feb 28, 2014 Primary completion: Dec 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02004275, this PHASE1/PHASE2 trial focuses on Multiple Myeloma in Relapse and remains ongoing. Sponsored by Alliance for Clinical Trials in Oncology, it has been updated 35 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~May 2017 · 2 months · monthly snapshot~May 2017 – ~Jul 2017 · 2 months · monthly snapshot~Jul 2017 – ~Feb 2018 · 7 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Feb 2022 · 8 months · monthly snapshot~Feb 2022 – ~Jan 2024 · 23 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshot~Jan 2026 – present · 8 months · monthly snapshot

Change History

35 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE1/PHASE2

    Status: Active Not Recruiting → Unknown

  2. Sep 2025 — Jan 2026 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  3. Sep 2024 — Sep 2025 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Jan 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 30 earlier versions

  1. Feb 2022 — Jan 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Jun 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jan 2021 — Jun 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE1_PHASE2

  6. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE1_PHASE2

  7. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE1_PHASE2

  8. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE1_PHASE2

  9. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE1_PHASE2

  10. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

  11. Dec 2019 — Feb 2020 [monthly]

    Recruiting PHASE1_PHASE2

  12. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE1_PHASE2

  13. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE1_PHASE2

  14. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE1_PHASE2

  15. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE1_PHASE2

  16. Mar 2019 — Jun 2019 [monthly]

    Recruiting PHASE1_PHASE2

  17. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE1_PHASE2

  18. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  19. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE1_PHASE2

  20. Oct 2018 — Dec 2018 [monthly]

    Recruiting PHASE1_PHASE2

  21. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE1_PHASE2

  22. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE1_PHASE2

  23. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Suspended → Recruiting

  24. Jun 2018 — Jul 2018 [monthly]

    Suspended PHASE1_PHASE2

  25. Feb 2018 — Jun 2018 [monthly]

    Suspended PHASE1_PHASE2

  26. Jul 2017 — Feb 2018 [monthly]

    Suspended PHASE1_PHASE2

    Status: Recruiting → Suspended

  27. May 2017 — Jul 2017 [monthly]

    Recruiting PHASE1_PHASE2

  28. Mar 2017 — May 2017 [monthly]

    Recruiting PHASE1_PHASE2

  29. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE1_PHASE2

  30. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alliance for Clinical Trials in Oncology
  • Celgene Corporation
  • Millennium Pharmaceuticals, Inc.
  • National Cancer Institute (NCI)
Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United States , Adrian, United States , Albuquerque, United States , Allentown, United States , Anaconda, United States , Anacortes, United States , Anchorage, United States , Ann Arbor, United States , Ashland, United States , Augusta, United States and 221 more locations